Dr. Charles C Debattista, MD is a Psychiatrist - General practicing in Palo Alto, CA
He has not yet shared a personalized biography with Doctor.com.
| University | Degree | Focus | Graduated |
|---|---|---|---|
| University of California | Medical Degree | 1989 | |
| University of Ca, San Francisco, School of Medicine, San Francisco Ca | Other Degree | 1989 |
| Institution | Focus | Year |
|---|---|---|
| Internship - Stanford University Medical Center CA | 1990 | |
| Residency - Stanford University Hospital, Psychiatry | Not Specified | |
| Residency - Stanford University Hospital | Not Specified | |
| Residency - Stanford University Medical Center | 1993 | |
| Residency - Stanford University Program | Not Specified | |
| Fellowship - Stanford University Medical Center CA | 1993 |
| Certification | Cert. Body | Year |
|---|---|---|
| Psychiatry | Psychiatry and Neurology | Not Specified |
| Psychiatry | Psychiatry and Neurology | 1995 |
| Distinction | Institution | Year |
|---|---|---|
| America's Best Doctors | ||
| Psychiatry, Best Doctors | 2009-2010 | |
| Review Article of the Year, Primary Psychiatry | 2004 | |
| Teacher of the Year, Dept. Of Psychiatry | 1998, 1998 |
| Publication | Publisher | Title | Published |
|---|---|---|---|
| Other Publication | NEUROPSYCHIATRIC DISEASE AND TREATMENT | Measuring severe adverse events | 2012 |
| Other Publication | JOURL OF PSYCHIATRIC RESEARCH | The use of referenced-EEG (rEEG) in assisting medication selection for the treatment of depression | 2011 |
| Other Publication | Current drug safety | Safety considerations of the use of second generation antipsychotics | 2010 |
| Other Publication | PSYCHONEUROENDOCRINOLOGY | Effects of major depression diagnosis and cortisol levels on indices of neurocognitive function | 2009 |
| Other Publication | CONTEMPORARY CLINICAL TRIALS | A multisite trial of mifepristone for the treatment of psychotic depression | 2009 |
| Other Publication | CNS DRUGS | Utility of Atypical Antipsychotics in the Treatment of Resistant Unipolar Depression | 2009 |
| Other Publication | JAMA-JOURL OF THE AMERICAN MEDICAL ASSOCIATION | Sildefil treatment of women with antidepressant-associated sexual dysfunction - A r | 2008 |
| Other Publication | Neuropsychiatric disease and treatment | Depression and smoking cessation: does the evidence support psychiatric practice? | 2007 |
| Other Publication | Anls of clinical psychiatry | Modafinil augmentation of selective serotonin reuptake inhibitor therapy | 2007 |
| Other Publication | BIOLOGICAL PSYCHIATRY | Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major | 2006 |
| Other Publication | BIOLOGICAL PSYCHIATRY | The neuropsychological profile of psychotic major depression and its relation to cortisol | 2006 |
| Other Publication | BEHAVIOURAL BRAIN RESEARCH | The efficacy of mifepristone in the reduction | 2006 |
| Other Publication | JOURL OF PSYCHOPHARMACOLOGY | Augmentation and combition strategies for depression | 2006 |
| Other Publication | TRENDS IN ENDOCRINOLOGY AND METABOLISM | The use of mifepristone in the treatment of neuropsychiatric disorders | 2006 |
| Other Publication | CNS SPECTRUMS | Modafinil augmentation of SSRI therapy in patients with major depressive disorder | 2006 |
| Other Publication | JOURL OF PSYCHIATRIC RESEARCH | Detecting psychotic major depression using psychiatric rating scales | 2006 |
| Other Publication | Current psychiatry reports | Update on augmentation of antidepressant response in resistant depression. | 2005 |
| Other Publication | JOURL OF CLINICAL PSYCHOPHARMACOLOGY | The efficacy of divalproex sodium in the treatment of agitation associated with major depression | 2005 |
| Other Publication | JOURL OF CLINICAL PSYCHIATRY | A placebo-controlled, randomized | 2005 |
| Other Publication | Current Alzheimer research | C-1073 (mifepristone) in the adjunctive treatment of Alzheimer's disease. | 2005 |
| Other Publication | Expert review of neurotherapeutics | Executive dysfunction in major depressive disorder. | 2005 |
| Other Publication | JOURL OF CLINICAL PSYCHIATRY | A multicenter, placebo | 2005 |
| Other Publication | PSYCHONEUROENDOCRINOLOGY | HPA axis activation in major depression and response to fluoxetine: a pilot study | 2004 |
| Other Publication | JOURL OF CLINICAL PSYCHOPHARMACOLOGY | A prospective trial of modafinil as an adjunctive treatment of major depression | 2004 |
| Other Publication | ACTA AESTHESIOLOGICA SCANDIVICA | Seizure duration with remifentanil | 2003 |
| Other Publication | JOURL OF CLINICAL PSYCHIATRY | Adjunct modafinil for the short-term treatment of fatigue | 2003 |
| Other Publication | Expert opinion on drug safety | Safety of antidepressants in the elderly. | 2003 |
| Other Publication | JOURL OF CLINICAL PSYCHOPHARMACOLOGY | A prospective trial of bupropion SR augmentation of partial | 2003 |
| Other Publication | JOURL OF CLINICAL ANESTHESIA | The timing of electroconvulsive therapy | 2003 |
| Other Publication | ACTA AESTHESIOLOGICA SCANDIVICA | Fetal heart rate decelerations during ECT-induced seizures: is it important? | 2003 |
| Other Publication | BIOLOGICAL PSYCHIATRY | An open label trial of C-1073 (mifepristone) for psychotic major depression | 2002 |
| Other Publication | JOURL OF MOLECULAR NEUROSCIENCE | Slowing the progression of cognitive decline in Alzheimer's disease using mifepristone | 2002 |
| Other Publication | AMERICAN JOURL OF PSYCHIATRY | Cortisol feedback during the HPA quiescent period in patients with major depression | 2001 |
| Other Publication | JOURL OF ECT | Is electroconvulsive therapy effective for the depressed patient | 2001 |
| Other Publication | JOURL OF AFFECTIVE DISORDERS | Sertraline versus imipramine to prevent relapse in chronic depression | 2001 |
| Other Publication | ANLS OF INTERL MEDICINE | Psychopharmacologic treatment strategies for depression, bipolar disorder, and schizophrenia | 2001 |
| Other Publication | AMERICAN JOURL OF PSYCHIATRY | Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients | 2000 |
| Other Publication | Posener, J. A., Debattista, C., Williams, G. H., Kraemer, H. C., Kaleh | 24-hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major | 2000 |
| Other Publication | AMERICAN JOURL OF PSYCHIATRY | Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness | 2000 |
| Other Publication | JOURL OF CLINICAL PSYCHOPHARMACOLOGY | Pramipexole augmentation of a selective serotonin reuptake inhibitor in the treatment of depression | 2000 |
| Other Publication | JOURL OF ECT | Negative-pressure pulmory edema: A potential mazard in patients undergoing ECT | 1999 |
| Other Publication | JOURL OF CLINICAL PSYCHIATRY | The Texas Medication Algorithm Project | 1999 |
| Other Publication | Schatzberg, A. F., Debattista, C. | Phenomenology and treatment of agitation | 1999 |
| Other Publication | JOURL OF ECT | ECT in dissociative identity disorder and comorbid depression | 1998 |
| Other Publication | BIOLOGICAL PSYCHIATRY | Serotonergic synergism | 1998 |
| Other Publication | PSYCHOPHARMACOLOGY BULLETIN | Developing treatment algorithms for unipolar depression in cyberspace | 1998 |
| Other Publication | AMERICAN JOURL OF PSYCHIATRY | Treatment of psychotic depression | 1997 |
| Other Publication | AMERICAN JOURL OF PSYCHIATRY | Development of obsessive symptoms during nefazodone treatment | 1996 |
| Other Publication | HEADACHE | SUMATRIPTAN PROPHYLAXIS FOR POSTELECTROCONVULSIVE THERAPY HEADACHES | 1995 |
| Other Publication | AMERICAN JOURL OF PSYCHIATRY | PHYSICAL SYMPTOMS ASSOCIATED WITH PAROXETINE WITHDRAWAL | 1995 |
Dr. Charles C Debattista, MD has not yet indicated the hospitals that he is affiliated with.
Years In Practice: 28 (started in 1996)
Accepts New Patients: Yes
Dr. Charles C Debattista, MD has not yet listed the medications that he commonly prescribes.
Dr. Charles C Debattista, MD has not yet added any information about his practice's billing policies and payment options.
